(A) F1.OVA kidney allografts were transplanted into GFP+ B6 recipients followed by co-adoptive transfer of 1 × 106 effector OT-I and P14 cells 2 days post-transplantation. Transplant recipients were harvested on days 6 (n = 5) and 56 (n = 4) to quantify CD8 TRM after gating on extravascular graft CD8+ T cells as shown in Fig. S1B.
(B) Percentage (representative d.56 plot, left) and ratio (graph, right) of CD45.1+ P14 to CD90.1+ OT-I cells on days 6 and 56.
(C) (Balb/c × B6.OVA) F1.OVA kidney allografts were transplanted into GFP+ B6 recipients followed by co-adoptive transfer of 1 × 106 CD90.1/90.2+ effector OT-I cells and CD45.1+ effector OT-3 cells 2 days post-transplantation. Transplant recipients were harvested on days 6 (n = 5) and 56 (n = 4) to quantify CD8 TRM after gating on extravascular graft CD8+ T cells as shown in Fig. S1B.
(D) Percentage (representative d.56 plot, left) and ratio (graph, right) of OT-3 to OT-I cells on days 6 and 56.
(E) Percentage (representative plots, left) of OT-I and OT-3 cells expressing TRM cell markers and percentage (graph, right) of OT-I and OT-3 cells that were CD69+ in the renal allograft on day 56.
P values were determined by (B, D, E) two-tailed paired t test.